Patents by Inventor John H. BAILLIE

John H. BAILLIE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Bioerodible implant for long-term drug delivery and associated methods of manufacture and use
    Patent number: 11833244
    Abstract: A drug delivery system is provided in the form of a controlled release, bioerodible pellet for subdermal implantation. The pellet is bioerodible, and provides for the sustained release of a pharmacologically active agent over an extended time period. As such, the drug delivery system finds significant utility in chronic drug administration. Bioerosion products are water soluble, bioresorbed, or both, obviating the need for surgical removal of the implant. Methods for manufacturing and using the drug delivery system are also provided.
    Type: Grant
    Filed: November 19, 2021
    Date of Patent: December 5, 2023
    Assignee: Gesea Biosciences Inc.
    Inventors: John H. Baillie, Ruth Baillie, George Blouin, Newsha Farahani, Christopher Marx
  • BIOERODIBLE IMPLANT FOR LONG-TERM DRUG DELIVERY AND ASSOCIATED METHODS OF MANUFACTURE AND USE
    Publication number: 20220249365
    Abstract: A drug delivery system is provided in the form of a controlled release, bioerodible pellet for subdermal implantation. The pellet is bioerodible, and provides for the sustained release of a pharmacologically active agent over an extended time period. As such, the drug delivery system finds significant utility in chronic drug administration. Bioerosion products are water soluble, bioresorbed, or both, obviating the need for surgical removal of the implant. Methods for manufacturing and using the drug delivery system are also provided.
    Type: Application
    Filed: November 19, 2021
    Publication date: August 11, 2022
    Applicant: Gesea Biosciences Inc.
    Inventors: John H. Baillie, Ruth Baillie, George Blouin, Newsha Farahani, Christopher Marx
  • Bioerodible implant for long-term drug delivery and associated methods of manufacture and use
    Patent number: 11185496
    Abstract: A drug delivery system is provided in the form of a controlled release, bioerodible pellet for subdermal implantation. The pellet is bioerodible, and provides for the sustained release of a pharmacologically active agent over an extended time period. As such, the drug delivery system finds significant utility in chronic drug administration. Bioerosion products are water soluble, bioresorbed, or both, obviating the need for surgical removal of the implant. Methods for manufacturing and using the drug delivery system are also provided.
    Type: Grant
    Filed: January 28, 2019
    Date of Patent: November 30, 2021
    Assignee: GESEA BIOSCIENCES, INC.
    Inventors: John H. Baillie, Ruth Baillie, George Blouin, Newsha Farahani, Christopher Marx
  • Bioerodible contraceptive implant and methods of use thereof
    Patent number: 10406099
    Abstract: A contraceptive drug delivery system is provided in the form of a controlled release, bioerodible pellet for subdermal implantation. The pellet is bioerodible, and provides for the sustained release of a contraceptive agent over an extended time period. Bioerosion products are water soluble, bioresorbed, or both, obviating the need for surgical removal of the implant. Methods of using the drug delivery system, including in female contraception, are also provided.
    Type: Grant
    Filed: April 24, 2018
    Date of Patent: September 10, 2019
    Assignee: GESEA BIOSCIENCES, INC.
    Inventors: John H. Baillie, Ruth Baillie, George Blouin, Newsha Farahani, Christopher Marx
  • BIOERODIBLE IMPLANT FOR LONG-TERM DRUG DELIVERY AND ASSOCIATED METHODS OF MANUFACTURE AND USE
    Publication number: 20190151235
    Abstract: A drug delivery system is provided in the form of a controlled release, bioerodible pellet for subdermal implantation. The pellet is bioerodible, and provides for the sustained release of a pharmacologically active agent over an extended time period. As such, the drug delivery system finds significant utility in chronic drug administration. Bioerosion products are water soluble, bioresorbed, or both, obviating the need for surgical removal of the implant. Methods for manufacturing and using the drug delivery system are also provided.
    Type: Application
    Filed: January 28, 2019
    Publication date: May 23, 2019
    Applicant: Gesea Biosciences Inc.
    Inventors: John H. BAILLIE, Ruth BAILLIE, George BLOUIN, Newsha FARAHANI, Christopher MARX
  • Bioerodible implant for long-term drug delivery and associated methods of manufacture and use
    Patent number: 10188602
    Abstract: A drug delivery system is provided in the form of a controlled release, bioerodible pellet for subdermal implantation. The pellet is bioerodible, and provides for the sustained release of a pharmacologically active agent over an extended time period. As such, the drug delivery system finds significant utility in chronic drug administration. Bioerosion products are water soluble, bioresorbed, or both, obviating the need for surgical removal of the implant. Methods for manufacturing and using the drug delivery system are also provided.
    Type: Grant
    Filed: September 29, 2017
    Date of Patent: January 29, 2019
    Assignee: GESEA BIOSCIENCES INC.
    Inventors: John H. Baillie, Ruth Baillie, George Blouin, Newsha Farahani, Christopher Marx
  • BIOERODIBLE CONTRACEPTIVE IMPLANT AND METHODS OF USE THEREOF
    Publication number: 20180303659
    Abstract: A contraceptive drug delivery system is provided in the form of a controlled release, bioerodible pellet for subdermal implantation. The pellet is bioerodible, and provides for the sustained release of a contraceptive agent over an extended time period. Bioerosion products are water soluble, bioresorbed, or both, obviating the need for surgical removal of the implant. Methods of using the drug delivery system, including in female contraception, are also provided.
    Type: Application
    Filed: April 24, 2018
    Publication date: October 25, 2018
    Applicant: Gesea Biosciences Inc.
    Inventors: John H. BAILLIE, Ruth BAILLIE, George BLOUIN, Newsha FARAHANI, Christopher MARX
  • Bioerodible contraceptive implant and methods of use thereof
    Patent number: 9980850
    Abstract: A contraceptive drug delivery system is provided in the form of a controlled release, bioerodible pellet for subdermal implantation. The pellet is bioerodible, and provides for the sustained release of a contraceptive agent over an extended time period. Bioerosion products are water soluble, bioresorbed, or both, obviating the need for surgical removal of the implant. Methods of using the drug delivery system, including in female contraception, are also provided.
    Type: Grant
    Filed: September 29, 2017
    Date of Patent: May 29, 2018
    Assignee: GESEA BIOSCIENCES, INC.
    Inventors: John H. Baillie, Ruth Baillie, George Blouin, Newsha Farahani, Christopher Marx
  • BIOERODIBLE CONTRACEPTIVE IMPLANT AND METHODS OF USE THEREOF
    Publication number: 20180085248
    Abstract: A contraceptive drug delivery system is provided in the form of a controlled release, bioerodible pellet for subdermal implantation. The pellet is bioerodible, and provides for the sustained release of a contraceptive agent over an extended time period. Bioerosion products are water soluble, bioresorbed, or both, obviating the need for surgical removal of the implant. Methods of using the drug delivery system, including in female contraception, are also provided.
    Type: Application
    Filed: September 29, 2017
    Publication date: March 29, 2018
    Applicant: Gesea Biosciences Inc.
    Inventors: John H. BAILLIE, Ruth BAILLIE, George BLOUIN, Newsha FARAHANI, Christopher MARX
  • BIOERODIBLE IMPLANT FOR LONG-TERM DRUG DELIVERY AND ASSOCIATED METHODS OF MANUFACTURE AND USE
    Publication number: 20180085305
    Abstract: A drug delivery system is provided in the form of a controlled release, bioerodible pellet for subdermal implantation. The pellet is bioerodible, and provides for the sustained release of a pharmacologically active agent over an extended time period. As such, the drug delivery system finds significant utility in chronic drug administration. Bioerosion products are water soluble, bioresorbed, or both, obviating the need for surgical removal of the implant. Methods for manufacturing and using the drug delivery system are also provided.
    Type: Application
    Filed: September 29, 2017
    Publication date: March 29, 2018
    Applicant: Gesea Biosciences Inc.
    Inventors: John H. BAILLIE, Ruth BAILLIE, George BLOUIN, Newsha FARAHANI, Christopher MARX